NEW YORK, Jan. 20, 2023 /PRNewswire/ — Ro, the leading direct-to-patient healthcare company, announced today the launch of the Ro Body Program, a comprehensive weight loss program that provides access to GLP-1 medications, the most effective prescription obesity treatments available. Ro aims to help millions of Americans living with obesity achieve their weight loss goals through access to prescription treatment supported by personalized provider care, diagnostic testing with at-home sample collection, and 1:1 coaching from nurses.

Read more here.